Back to top
more

Illumina (ILMN)

(Delayed Data from NSDQ)

$161.93 USD

161.93
3,100,660

+2.84 (1.79%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $161.85 -0.08 (-0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Reasons to Retain Penumbra Stock in Your Portfolio for Now

by Zacks Equity Research

PEN's expanding thrombectomy portfolio and growing international footprint support momentum, even as FX and macro pressures pose risks.

Zacks Equity Research

Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?

by Zacks Equity Research

DGX banks on acquisitions, advanced diagnostics and cost discipline, even as debt levels and macro pressures pose risks.

Zacks Equity Research

Is This the Right Time to Add Veracyte Stock to Your Portfolio?

by Zacks Equity Research

VCYT's Afirma and Decipher fuel strong test volume growth and a debt-free balance sheet, but rising macro costs and expenses temper the outlook.

Zacks Equity Research

Abbott Stock May Benefit Following Volt PFA's FDA Approval

by Zacks Equity Research

ABT wins FDA approval for its Volt PFA System for AFib, paving the way for U.S. launches and EU expansion after earlier CE Mark clearance.

Zacks Equity Research

TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch

by Zacks Equity Research

Thermo Fisher launches a global PPD CorEvitas Alzheimer's registry, enrolling its first patient to generate real-world safety and effectiveness data.

Zacks Equity Research

Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains?

by Zacks Equity Research

Illumina (ILMN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks Equity Research

National Vision Stock Surges 154.6% in a Year: What's Driving it?

by Zacks Equity Research

EYE shares jump 154% in a year as America's Best fuels comps, new stores and fleet optimization, showing early gains from strategic execution.

Zacks Equity Research

Should You Continue to Hold CRL Stock in Your Portfolio for Now?

by Zacks Equity Research

Charles River gains from strong RMS demand, strategic partnerships and solid finances but faces macro and competitive pressures in 2025.

Zacks Equity Research

Should Investors Hold Chemed Stock in Their Portfolio Now?

by Zacks Equity Research

CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.

Nilanjan Choudhury headshot

Can These 5 Relative Price Strength Stocks Lead in 2026?

by Nilanjan Choudhury

HG, KGC, ILMN, CMC and LVS are flashing relative strength heading into 2026 - could they lead the next market leg higher?